Neurocrine Biosciences Inc Note 2.250 5/1 shares owned by Citigroup
Quarter-by-quarter ownership of Neurocrine Biosciences Inc Note 2.250 5/1 shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Neurocrine Biosciences Inc Note 2.250 5/1
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences Inc Note 2.250 5/1 held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences Inc Note 2.250 5/1 by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $1.8M | 998k | 1.80 |
| 2023-12-31 | $1.7M | 962k | 1.72 |
| 2023-09-30 | $137k | 92k | 1.48 |
| 2023-03-31 | $93k | 69k | 1.34 |
| 2022-12-31 | $207k | 131k | 1.58 |
| 2021-12-31 | $221k | 177k | 1.25 |
| 2021-03-31 | $28k | 21k | 1.33 |
| 2020-12-31 | $113k | 82k | 1.38 |
| 2020-09-30 | $41k | 30k | 1.37 |
| 2020-06-30 | $33k | 20k | 1.65 |
| 2020-03-31 | $27k | 21k | 1.29 |
| 2019-12-31 | $32k | 21k | 1.52 |
| 2019-09-30 | $252k | 184k | 1.37 |
| 2018-12-31 | $1.1M | 958k | 1.19 |
Top funds holding Neurocrine Biosciences Inc Note 2.250 5/1
View all funds holding Neurocrine Biosciences Inc Note 2.250 5/1